Multinational cannabis company Clever Leaves has signed an agreement to supply pharmaceutical manufacturer IDT Australia with two varieties of bulk GACP-certified flower from its Portugal facility.
As part of the arrangement, Clever Leaves has made its first commercial shipment of high-THC dried flower to Australia. The company said it aims to widen its distribution channel with IDT, expand its product portfolio to meet Australian demand and help plug the flower shortage.
CEO Kyle Detwiler said: “Clever Leaves’ supply agreement with IDT is a great step forward to distribute high-quality products for those in need in Australia, and we could not be more thrilled to be a part of the remedy.
“With the Clever Leaves Portugal facility operating commercially, our flower capabilities are now open for business, providing Australians with additional medical cannabis flower products and fulfilling growing patient demand.”
IDT CEO David Sparling added: “Australia currently has limited access to quality and affordable GMP medicinal cannabis flower products for patients in need.
“Clever Leaves is a dependable and reputable supplier which meets IDT’s stringent GMP requirements, and we see this partnership as a strategic solution which creates a great opportunity for both companies.”